Literature DB >> 6403596

Biochemical and histopathological studies on patients with mucopolysaccharidoses, two of whom had been treated by fibroblast transplantation.

J Crow, D A Gibbs, W Cozens, E Spellacy, R W Watts.   

Abstract

Biochemical and pathological observations on tissues from two patients with Hurler disease (mucopolysaccharidosis IH; alpha-L-iduronidase deficiency) who had been treated by fibroblast transplants as a means of enzyme replacement treatment are reported. These results and those obtained in three surgical specimens [ligamentum flavum with dura mater from a case of Scheie disease (mucopolysaccharidosis IS; alpha-L-iduronidase deficiency); a fetus with Hurler disease; and tonsil from a patient with Hunter disease (mucopolysaccharidosis II; alpha-L-idurono-2-sulphate sulphatase deficiency)] illustrate the inadequacy of routine histological processing to demonstrate the abnormal glycosaminoglycan accumulation in this group of diseases. A combined approach using histochemistry and electron microscopy enables the extent of both extracellular and intracellular involvement to be assessed. The fetus (20 wk gestation) already showed evidence of Hurler disease. The pathological appearances in both of the fibroblast-transplanted patients were those which would have been expected in patients dying with unmodified Hurler disease. There was no detectable alpha-L-iduronidase activity in the brain, liver, kidney or in fibroblasts cultured from either the transplantation sites or from remote subcutaneous sites in either of the transplanted patients. These results are discussed from the viewpoint of their bearing on the pathophysiology of the mucopolysaccharidoses and proposals for their treatment by enzyme replacement.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403596      PMCID: PMC498237          DOI: 10.1136/jcp.36.4.415

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  42 in total

Review 1.  Pre- and postnatal pathology, enzyme treatment, and unresolved issues in five lysosomal disorders.

Authors:  G Hug
Journal:  Pharmacol Rev       Date:  1978-12       Impact factor: 25.468

2.  Neuroanatomical and electroencephalographic correlations in Sanfilippo syndrome, type A.

Authors:  R L Kriel; W A Hauser; J H Sung; Z Posalaky
Journal:  Arch Neurol       Date:  1978-12

3.  Localisation of sulphated glycosaminoglycans in the mucopolysaccharidoses by a simple technique using cryostat sections.

Authors:  J Dorling
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411

4.  The treatment of lysosomal storage diseases by fibroblast transplantation: some preliminary observations.

Authors:  D A Gibbs; E Spellacy; A E Roberts; R W Watts
Journal:  Birth Defects Orig Artic Ser       Date:  1980

5.  Direct demonstration of binding of a lysosomal enzyme, alpha-L-iduronidase, to receptors on cultured fibroblasts.

Authors:  L H Rome; B Weissmann; E F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

6.  Enzyme replacement therapy by fibroblast transplantation: long-term biochemical study in three cases of Hunter's syndrome.

Authors:  M F Dean; R L Stevens; H Muir; P F Benson; L R Button; R L Anderson; A Boylston; J Mowbray
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

7.  Glaucoma in a case of Hurler disease.

Authors:  E Spellacy; J L Bankes; J Crow; R Dourmashkin; D Shah; R W Watts
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

8.  Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain.

Authors:  A S Dekaban; G Constantopoulos
Journal:  Acta Neuropathol       Date:  1977-07-15       Impact factor: 17.088

9.  Cytochemistry of the skin of patients with mucopolysaccharidoses.

Authors:  S S Spicer; A J Garvin; J A Simson; V Wertelecki
Journal:  Histochem J       Date:  1978-03

10.  Pathologic findings in mucopolysaccharidosis type IIIB (Sanfilippo's sydnrome B).

Authors:  M G Hadfield; N R Ghatak; I Nakoneczna; H R Lippman; E C Myer; G Constantopoulos; R M Bradley
Journal:  Arch Neurol       Date:  1980-10
View more
  8 in total

1.  Neuropathological and clinical correlations in Hurler disease.

Authors:  R W Watts; E Spellacy; J H Adams
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses.

Authors:  Francyne Kubaski; Yasuyuki Suzuki; Kenji Orii; Roberto Giugliani; Heather J Church; Robert W Mason; Vũ Chí Dũng; Can Thi Bich Ngoc; Seiji Yamaguchi; Hironori Kobayashi; Katta M Girisha; Toshiyuki Fukao; Tadao Orii; Shunji Tomatsu
Journal:  Mol Genet Metab       Date:  2016-12-22       Impact factor: 4.797

3.  Newborn screening and diagnosis of mucopolysaccharidoses: application of tandem mass spectrometry.

Authors:  Shunji Tomatsu; Francyne Kubaski; Kazuki Sawamoto; Robert W Mason; Eriko Yasuda; Tsutomu Shimada; Adriana M Montaño; Seiji Yamaguchi; Yasuyuki Suzuki; Tadao Orii
Journal:  Nihon Masu Sukuriningu Gakkai Shi       Date:  2014

4.  Stereological and morphometric analysis of dermal fibroblasts before and after bone marrow transplantation in a case of mucopolysaccharidosis I Scheie phenotype.

Authors:  M Costa; J García Valero; C Navarro
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

5.  Molecular Genetics and Metabolism Report Long-term follow-up of post hematopoietic stem cell transplantation for Hurler syndrome: clinical, biochemical, and pathological improvements.

Authors:  Eriko Yasuda; William Mackenzie; Kristen Ruhnke; Tsutomu Shimada; Robert W Mason; Jozef Zustin; Paul L Martin; Mihir Thacker; Tadao Orii; Yoshimichi Sai; Shunji Tomatsu
Journal:  Mol Genet Metab Rep       Date:  2015-03

Review 6.  Establishment of glycosaminoglycan assays for mucopolysaccharidoses.

Authors:  Shunji Tomatsu; Tsutomu Shimada; Robert W Mason; Adriana M Montaño; Joan Kelly; William A LaMarr; Francyne Kubaski; Roberto Giugliani; Aratrik Guha; Eriko Yasuda; William Mackenzie; Seiji Yamaguchi; Yasuyuki Suzuki; Tadao Orii
Journal:  Metabolites       Date:  2014-08-11

Review 7.  IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport.

Authors:  Ruben J Boado
Journal:  Pharmaceutics       Date:  2022-07-15       Impact factor: 6.525

8.  In utero adenine base editing corrects multi-organ pathology in a lethal lysosomal storage disease.

Authors:  Sourav K Bose; Brandon M White; Meghana V Kashyap; Apeksha Dave; Felix R De Bie; Haiying Li; Kshitiz Singh; Pallavi Menon; Tiankun Wang; Shiva Teerdhala; Vishal Swaminathan; Heather A Hartman; Sowmya Jayachandran; Prashant Chandrasekaran; Kiran Musunuru; Rajan Jain; David B Frank; Philip Zoltick; William H Peranteau
Journal:  Nat Commun       Date:  2021-07-13       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.